| pubmed-article:18474738 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18474738 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:18474738 | lifeskim:mentions | umls-concept:C0292777 | lld:lifeskim |
| pubmed-article:18474738 | lifeskim:mentions | umls-concept:C1441055 | lld:lifeskim |
| pubmed-article:18474738 | lifeskim:mentions | umls-concept:C0449255 | lld:lifeskim |
| pubmed-article:18474738 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18474738 | pubmed:dateCreated | 2008-5-13 | lld:pubmed |
| pubmed-article:18474738 | pubmed:abstractText | The neuromyelitis optica IgG autoantibody (NMO-IgG) is a validated biomarker for NMO and an emerging spectrum of inflammatory central nervous system-demyelinating disorders. Its antigen is the astrocytic water channel aquaporin-4; NMO-IgG has not been described in a cancer context. | lld:pubmed |
| pubmed-article:18474738 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18474738 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18474738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18474738 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18474738 | pubmed:month | May | lld:pubmed |
| pubmed-article:18474738 | pubmed:issn | 1538-3687 | lld:pubmed |
| pubmed-article:18474738 | pubmed:author | pubmed-author:PittockSean... | lld:pubmed |
| pubmed-article:18474738 | pubmed:author | pubmed-author:LennonVanda... | lld:pubmed |
| pubmed-article:18474738 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18474738 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:18474738 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18474738 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18474738 | pubmed:pagination | 629-32 | lld:pubmed |
| pubmed-article:18474738 | pubmed:dateRevised | 2008-12-8 | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:meshHeading | pubmed-meshheading:18474738... | lld:pubmed |
| pubmed-article:18474738 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18474738 | pubmed:articleTitle | Aquaporin-4 autoantibodies in a paraneoplastic context. | lld:pubmed |
| pubmed-article:18474738 | pubmed:affiliation | Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. | lld:pubmed |
| pubmed-article:18474738 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18474738 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:361 | entrezgene:pubmed | pubmed-article:18474738 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18474738 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18474738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18474738 | lld:pubmed |
